{"id":143060,"date":"2021-10-28T10:47:26","date_gmt":"2021-10-28T01:47:26","guid":{"rendered":"https:\/\/www.fukuoka-now.com\/?post_type=news&#038;p=143060&#038;lang=en"},"modified":"2021-10-28T10:47:26","modified_gmt":"2021-10-28T01:47:26","slug":"kumamoto-based-km-biologics-accelerates-its-vaccine-development","status":"publish","type":"news","link":"https:\/\/www.fukuoka-now.com\/en\/news\/kumamoto-based-km-biologics-accelerates-its-vaccine-development\/","title":{"rendered":"Kumamoto-based KM Biologics Accelerates its Vaccine Development"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">The domestic producer of the new coronavirus vaccine had applied for the government\u2019s early approval program to meet the demands for the expected third injections period. The company\u2019s inactivated vaccine is considered to have reduced frequency of developing side effects, compared to mRNA vaccines including Phyzer and Moderna doses. Clinical trial for adults will begin by the end of 2021, before another trial for children between 6 m\/o and 17 y\/o in the spring of 2022. <\/span><b>Source: <\/b><a href=\"https:\/\/www.asahi.com\/articles\/ASPBT62GRPBTULFA02T.html\" rel=\"noopener\" target=\"_blank\"><span style=\"font-weight: 400;\">Asahi<\/span><\/a><span style=\"font-weight: 400;\"> \/ <\/span><a href=\"https:\/\/kumanichi.com\/articles\/444175\" rel=\"noopener\" target=\"_blank\"><span style=\"font-weight: 400;\">Kumanichi<\/span><\/a><span style=\"font-weight: 400;\"> \/ <\/span><a href=\"https:\/\/www3.nhk.or.jp\/lnews\/kumamoto\/20211025\/5000013809.html\" rel=\"noopener\" target=\"_blank\"><span style=\"font-weight: 400;\">NHK<\/span><\/a><\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-143057\" src=\"https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2021\/10\/km-biologics.jpg?resize=1024%2C554&#038;ssl=1\" alt=\"\" width=\"1024\" height=\"554\" srcset=\"https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2021\/10\/km-biologics.jpg?resize=1024%2C554&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2021\/10\/km-biologics.jpg?resize=300%2C162&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2021\/10\/km-biologics.jpg?resize=768%2C415&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2021\/10\/km-biologics.jpg?w=1400&amp;ssl=1 1400w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><\/p>\n<p><b>Disclaimer<\/b><span style=\"font-weight: 400;\">: Fukuoka Now posts summaries of Kyushu area news for those who cannot read Japanese. These are mostly summaries of publicly posted news from the Japanese media. Errors might occur during translation, those are ours. Images are sourced separately and are for illustrative purposes only. Use<\/span><a href=\"http:\/\/www.fukuoka-now.com\/contact\/\"> <span style=\"font-weight: 400;\">this form<\/span><\/a><span style=\"font-weight: 400;\"> to send feedback. Please share links to this page, it helps us.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">English language Fukuoka &amp; Kyushu local news summaries are <\/span><a href=\"https:\/\/www.fukuoka-now.com\/en\/news\/archive\/\"><span style=\"font-weight: 400;\">posted here<\/span><\/a><span style=\"font-weight: 400;\"> every day.<\/span><br \/>\n<span style=\"font-weight: 400;\">Or sign up for our <\/span><a href=\"https:\/\/www.fukuoka-now.com\/en\/mailmagazine\/\"><span style=\"font-weight: 400;\">free weekly newsletter<\/span><\/a><span style=\"font-weight: 400;\"> with all the top stories in one convenient email.<\/span><br \/>\n<span style=\"font-weight: 400;\">More Kyushu news on<\/span><a href=\"https:\/\/twitter.com\/FukuokaNow\"> <span style=\"font-weight: 400;\">Twitter<\/span><\/a><span style=\"font-weight: 400;\">,<\/span><a href=\"https:\/\/www.instagram.com\/fukuokanews\/\"> <span style=\"font-weight: 400;\">Instagram<\/span><\/a><span style=\"font-weight: 400;\">, and<\/span><a href=\"https:\/\/www.facebook.com\/fukuokanow\"> <span style=\"font-weight: 400;\">Facebook<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The domestic producer of the new coronavirus vaccine had applied for the government\u2019s early approval program to meet the demands for the expected third injections period. The company\u2019s inactivated vaccine is&#8230;<\/p>\n","protected":false},"author":29305,"featured_media":143057,"comment_status":"open","ping_status":"closed","template":"","tags":[5175],"class_list":["post-143060","news","type-news","status-publish","has-post-thumbnail","hentry","tag-corona","location-kumamoto-prefecture","news-category-technology","en-US"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/news\/143060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/users\/29305"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/comments?post=143060"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/media\/143057"}],"wp:attachment":[{"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/media?parent=143060"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/tags?post=143060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}